| Employment |
| Company: HCA Healthcare/Sarah Cannon |
| Recipient: You |
|
| Leadership |
| Company: HCA Healthcare / Sarah Cannon |
| Recipient: You |
|
| Stock and Other Ownership Interests |
| Company: HCA Healthcare / Sarah Cannon |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: GRAIL |
| Recipient: Your Institution |
| Company: Roche |
| Recipient: Your Institution |
| Company: Vincerx Pharma |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Bicycle Therapeutics |
| Recipient: Your Institution |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Roche/Genentech |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: MedImmune |
| Recipient: Your Institution |
| Company: Macrogenics |
| Recipient: Your Institution |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Agios |
| Recipient: Your Institution |
| Company: Jounce Therapeutics |
| Recipient: Your Institution |
| Company: Moderna Therapeutics |
| Recipient: Your Institution |
| Company: Verastem |
| Recipient: Your Institution |
| Company: Tesaro |
| Recipient: Your Institution |
| Company: TG Therapeutics |
| Recipient: Your Institution |
| Company: Vertex |
| Recipient: Your Institution |
| Company: BioAtla |
| Recipient: Your Institution |
| Company: Harpoon therapeutics |
| Recipient: Your Institution |
| Company: Arch |
| Recipient: Your Institution |
| Company: Arvinas |
| Recipient: Your Institution |
| Company: Revolution Medicines |
| Recipient: Your Institution |
| Company: Array BioPharma |
| Recipient: Your Institution |
| Company: Kymab |
| Recipient: Your Institution |
| Company: Pfizer |
| Recipient: Your Institution |
| Company: Takeda/Millennium |
| Recipient: Your Institution |
| Company: Foundation Medicine |
| Recipient: Your Institution |
| Company: EMD Serono |
| Recipient: Your Institution |
| Company: ARMO BioSciences |
| Recipient: Your Institution |
| Company: CALGB |
| Recipient: Your Institution |
| Company: Hengrui Therapeutics |
| Recipient: Your Institution |
| Company: XBiotech |
| Recipient: Your Institution |
| Company: Zymeworks |
| Recipient: Your Institution |
| Company: Coordination Pharmaceuticals |
| Recipient: Your Institution |
| Company: Gossamer Bio |
| Recipient: Your Institution |
| Company: Ryvu Therapeutics |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Celgene |
| Recipient: Your Institution |
| Company: CytomX Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
|
| (OPTIONAL) Open Payments Link |
|
| Open Payments URL: https://openpaymentsdata.cms.gov/physician/201030/summary |
|